Global Gastroesophageal Reflux Disease (GERD) Treatment Device Market Size By Type (Invasive, Non Invasive), By Application (Hospitals, Clinic), By Region, And Segment Forecasts, 2023 to 2032

The Global Gastroesophageal Reflux Disease (GERD) Treatment Device Market was valued at USD 1.1 billion in 2023 and is projected to surpass USD 2.3 billion by 2031, growing at a CAGR of 9.4% during the forecast period from 2023 to 2031. GERD treatment devices are gaining traction due to rising global prevalence of GERD, increasing awareness about minimally invasive treatment options, and technological advancements in reflux management devices. As the demand for alternatives to long-term medication use grows, devices such as LINX reflux management systems, electrical stimulation devices, and endoscopic solutions are becoming central to GERD treatment strategies.

Drivers

Rising Prevalence of GERD:

The increasing global incidence of GERD, exacerbated by lifestyle factors such as poor diet, obesity, and sedentary habits, is propelling the demand for effective long-term treatment solutions beyond conventional medication.

Technological Innovations in Treatment Devices:

The development of advanced treatment devices offering improved safety profiles, reduced side effects, and minimally invasive procedures is contributing to growing adoption rates among healthcare providers and patients alike.

Shifting Preference Toward Device-Based Therapies:

Many patients and physicians are seeking device-based GERD management due to concerns around long-term side effects of proton pump inhibitors (PPIs), boosting the demand for novel interventional approaches.

Restraints

High Cost of Advanced Devices:

The initial acquisition and procedural costs of GERD treatment devices remain high, which can hinder adoption, particularly in price-sensitive and underinsured markets.

Limited Clinical Awareness in Developing Regions:

A lack of clinical expertise and awareness regarding available GERD device therapies in developing regions poses a challenge for wider market penetration.

Opportunity

Emerging Markets and Untapped Populations:

Rapid urbanization, increasing healthcare expenditure, and a growing middle class in regions such as Asia-Pacific and Latin America present significant opportunities for market players to expand.

Integration with Smart Health Technologies:

Integration of GERD treatment devices with AI and remote monitoring systems opens new avenues for personalized care and improved treatment outcomes, offering competitive differentiation.

Market by System Type Insights

By system type, magnetic sphincter augmentation devices (such as LINX) held the largest market share in 2023. These devices are favored for their minimally invasive nature, reversibility, and proven efficacy in reducing reflux symptoms. However, electrical stimulation devices are projected to witness the highest growth due to ongoing R&D and positive clinical trial outcomes that support their safety and effectiveness.

Market by End-use Insights

In 2023, hospitals represented the largest end-use segment, supported by the availability of surgical infrastructure and skilled personnel for GERD device implantation. Meanwhile, ambulatory surgical centers (ASCs) are anticipated to register the fastest growth during the forecast period, driven by the increasing preference for outpatient procedures due to reduced costs and shorter recovery times.

Market by Regional Insights

North America dominated the GERD treatment device market in 2023, driven by high disease prevalence, favorable reimbursement frameworks, and widespread awareness of device-based solutions. However, Asia-Pacific is poised for the highest CAGR during the forecast period owing to rising healthcare access, growing awareness campaigns, and increasing investments in medical device innovation and infrastructure.

Competitive Scenario

Key players operating in the Global GERD Treatment Device Market include:

Medtronic plc

Torax Medical Inc. (Johnson & Johnson)

EndoGastric Solutions Inc.

LABORIE Medical Technologies

Medari Therapies Inc.

Mederi Therapeutics Inc.

Reflux Medical Inc.

These companies are leveraging strategies such as clinical innovation, regulatory approvals, and strategic partnerships to enhance their market presence. For example:

In 2023, EndoGastric Solutions expanded clinical access to its EsophyX Z+ device through new reimbursement approvals across Europe.

Medtronic launched a smart magnetic sphincter augmentation device in 2024, incorporating sensors for personalized treatment feedback.

Scope of Work – Global Gastroesophageal Reflux Disease (GERD) Treatment Device Market

Report Metric Details

Market Size (2023) USD 1.1 billion

Projected Market Size (2031) USD 2.3 billion

CAGR (2023–2031) 9.4%

Market Segments By System Type, By End-use, By Region

Growth Drivers Rising GERD prevalence, device innovations, shift from pharmaceuticals

Opportunities Emerging markets, AI-integrated devices

Key Market Developments

April 2023: Medtronic received FDA approval for a next-gen GERD device designed for real-time reflux detection and modulation.

September 2023: LABORIE acquired a US-based startup focused on AI-integrated endoscopic GERD diagnostics, aiming to expand its device portfolio.

January 2024: EndoGastric Solutions introduced its new EsophyX Z+ with improved transoral delivery mechanics for minimally invasive interventions.

FAQs

1) What is the current market size of the Global Gastroesophageal Reflux Disease (GERD) Treatment Device Market?

The GERD Treatment Device Market was valued at USD 1.1 billion in 2023.

2) What is the major growth driver of the Global Gastroesophageal Reflux Disease (GERD) Treatment Device Market?

The primary growth driver is the rising prevalence of GERD and the shift from long-term medication use to effective, minimally invasive device-based treatments.

3) Which is the largest region during the forecast period in the Global Gastroesophageal Reflux Disease (GERD) Treatment Device Market?

North America held the largest market share in 2023, while Asia-Pacific is expected to witness the fastest growth.

4) Which segment accounted for the largest market share in Global Gastroesophageal Reflux Disease (GERD) Treatment Device Market?

The magnetic sphincter augmentation device segment accounted for the largest share in 2023.

5) Who are the key market players in the Global Gastroesophageal Reflux Disease (GERD) Treatment Device Market?

Major players include Medtronic, Torax Medical, EndoGastric Solutions, LABORIE Medical Technologies, and Mederi Therapeutics.